for the APV initiative and the German Competence Net Obesity OBJECTIVE: Although there is evidence of increasing prevalence of impaired glucose metabolism in obese children from smaller single cohorts, data are lacking on the progression of glucose metabolism in this patient group. We aimed to assess the prevalence and the longitudinal course of impaired glucose metabolism assessed by oral glucose tolerance test (oGTT) in a large multi-center pediatric obesity registry. SUBJECTS: We performed an observational multicenter (n ¼ 84) cross-sectional (n ¼ 11 156) and longitudinal analysis (n ¼ 1008) on the course of glucose metabolism evaluated by oGTT in obese children documented in the Adiposity Patients Verlaufsbeobachtung (APV) registry. Patients were stratified with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and Type 2 diabetes (T2D), according to American Diabetes Association criteria. RESULTS: A total of 12.6% of the children presented with abnormal glucose metabolism (5.99% IFG, 5.51% IGT, 1.07% T2D). Body mass index (BMI) correlated modestly with 2-h blood glucose (r ¼ 0.04, Po0.001). In the 1008 patients with follow-up oGTT, metabolic parameters improved and the percentage of abnormal glucose metabolism decreased from 18.7 to 14.2%. Of the children with initial IGT, 70.6% converted to normal glucose tolerance. The improvement in oGTT results was associated with, but not dependent on, a reduction of BMI s.d. score. CONCLUSION: In summary, we provide evidence for significant improvement of oGTT parameters in obese children treated in specialized treatment centers, even though reduction in BMI was modest.
INTRODUCTION
With the high prevalence of obesity in children and adolescents, the rate of metabolic and cardiovascular sequelae of obesity increases. Although overt disease such as Type 2 diabetes (T2D) and cardiovascular disease are mostly diagnosed at adult age, the pathogenesis starts considerably earlier, already during childhood. Furthermore, there is ample evidence that children with obesity frequently accumulate cardiovascular risk factors such as elevated blood pressure, dyslipidemia and impaired glucose metabolism. 1 These also increase the risk for early-onset T2D 2 and are associated with premature death on a population basis. 3 Considering the fact that obesity in children generally persists into adulthood, there is hence a long exposure of individuals to these risk factors, which is likely to contribute to long-term morbidity and mortality. 4 However, although there is good evidence of impaired glucose metabolism in obese children from single cross-sectional cohorts, data are lacking on the progression of normal or abnormal glucose metabolism in obese children over time.
Applying data from a large obesity patient registry (Adiposity Patients Verlaufsbeobachtung (APV) 5 ) encompassing 167 centers specialized in pediatric obesity, we performed a large-scale multicenter longitudinal observational analysis on the course of glucose metabolism in obese children and adolescents. In addition to providing data on (i) the diagnostic management and (ii) the prevalence of abnormal glucose metabolism in a large data set of more than 11 000 obese children and adolescents, our objective was (iii) to assess the longitudinal course of glucose metabolism assessed by oral glucose tolerance test (oGTT) in obese children and adolescents.
PATIENTS AND METHODS
The APV data base
On the basis of German guidelines for diagnostics and treatment of overweight children and adolescents (http://www.a-g-a.de 6 ), a computer software using on the Visual FoxPro 9.0 compiler was developed for standardized longitudinal documentation of clinical care of pediatric obese patients (http://www.a-p-v.de 5 ). Currently, 167 outpatient and inpatient centers from Germany (n ¼ 159), Austria (n ¼ 6) and Switzerland (n ¼ 2) specialized in pediatric obesity continuously contribute pseudonymized anthropometric, clinical, laboratory and treatment data to the registry and 84 centers were contributing data on oGTTs. Each participating center complied with their local ethical and data management guidelines.
Selection of patients
Between 2000 and 2010, 182 748 patient visits of 61 905 overweight or obese patients were documented in the APV registry, of whom 11 956 underwent an oGTT. For detailed analyses of glucose metabolism, we applied the inclusion criteria of (i) body mass index (BMI) s.d. score (SDS) 41.28 (corresponding to the 90th centile ¼ cut off of overweight according to current guidelines 7 ), (ii) age X2 years and (iii) oGTT in venous samples with plasma glucose measured at least at 0 and 120 min. Exclusion criteria were (iv) syndromal obesity (1.1%) and (v) metformin treatment (0.2%). Such, analyses were performed in 11 156 patients, aged 12.9 ± 3.0 years with a mean BMI SDS of 2.60 ± 0.57 (BMI SDS 2.93 ± 0.66 according to WHO BMI references) and BMI of 31.4 ± 6.2 kg m À 2 . Pubertal stage according to Tanner recorded by physicians during clinical examination was available in 19.8% of the visits only. We therefore stratified children according to age groups (prepubertal: o10 years and o11 years, peripubertal: X10 to o14.5 years and X11 to o15 years, adolescent: X14.5 and X15.0 for girls and boys, respectively).
Patients were stratified for glucose metabolism pathology according to current WHO guidelines 8 7 ), a multivariable logistic regression model was applied. To control for clustering within treatment centers, a random variable was used (random intercept model with Cholesky covariance structure). The model was implemented with SAS proc glimmix, calculating the denominator degrees of freedom according to Kenward-Roger and optimization of iterations according to Newton-Raphson. Intra-class correlation (ICC) was 28.5%. Frequency of abnormal carbohydrate metabolism in BMI categories, adjusted for age and gender, was described by least-square means based on marginal frequencies of confounders with P-values adjusted for multiple comparisons (three BMI categories) according to Tukey-Kramer. 9 McNemar test was used to compare oGTT categories between baseline and follow-up. To compare baseline and follow-up oGTT-results, a multivariable linear model (change in area under the curve (AUC) glucose) or multivariable logistic model (abnormal oGTT result) was used with gender, age and BMI at baseline and observation period as dependent variables, using the same mixed modeling approach as described for the baseline models.
A P-value of o0.05 was considered significant; all analyses were performed with SAS 9.2 (Statistical Analysis Software, SAS Institute, NC, USA), using SAS BASE and SAS STAT on a Windows 7 environment.
RESULTS
Diagnostic management of glucose metabolism in the APV obesity treatment centers Of the 61 905 overweight and obese patients recorded in the APV registry, 19.31% were evaluated by oGTT, with 17.42% of them (n ¼ 10 786) undergoing at least one and 1.88% (n ¼ 1170) at least two oGTTs. There was no clear pattern in age differences between these three groups, but patients, who were tested at least twice, were more obese compared with patients with one or no oGTT (BMI SDS: 2.48±0.00 vs 2.60±0.01 vs 2.69±0.02; Po0.001 and BMI: 31.8±0.2 vs 31.3±0.1 vs 30.0±0.0 kg m À 2 ; Po0.001 for two, one or no oGTT performed, respectively). Also, the percentage of patients with syndromal obesity (2.34%) and metformin treatment (0.68%) was higher in patients with repetitive testing compared with patients with one (0.97 and 0.17%) or no (0.48 and 0.02%) oGTT. As syndromal obesity and metformin treatment affect the oGTT results, these patients were excluded from subsequent analyses. Of the remaining 11 156 patients, only 28.1% had baseline insulin available and not more than 14.70% had insulin levels recorded during the oGTT. Therefore, pathology classification was solely based on the plasma glucose levels in subsequent analyses.
Pathology of glucose metabolism in overweight patients Of the 11 156 patients (age 12.95 ± 2.96 years, BMI SDS 2.60 ± 0.58, BMI 31.4±6.2 kg m À 2 ) examined by oGTT, 6.04% were classified as IFG, 5.49% as IGT (or the combination of IFG and IGT) and 1.10% as T2D; hence 12.64% of the children presented with pathology in glucose metabolism. Children with more overt pathology (IGT or T2D) were significantly older, more obese and the percentage of girls was higher ( Figure 1 and Supplementary Table 2 ). However, the correlations between BMI SDS and BMI and plasma glucose parameters were rather weak, albeit significant, whereas the correlations with insulin parameters, if available, were stronger (Table 1) . Logistic regression analysis for abnormal glucose metabolism as dependent variable and including sex, age group and BMI category as independent variables identified older age (P ¼ 0.0011) and increasing BMI (Po0.0001) as significant predictors. Adjusted for age and gender, 11.5% of overweight, 13.3 of obese and 16.7% of extremely obese patients presented abnormal glucose metabolism (Po0.0005, Tukey-Kramer).
Only in 13.3% of the patients, who did have pathology, the oGTT was re-evaluated. This rate was even lower in obese children with normal oGTT (8.41%). In 57.9% of those patients with abnormal initial oGTT but lack of repetitive oGTT, anthropometric follow-up data were available. The BMI SDS (2.74 ± 0.59 vs 2.54 ± 0.66, Po0.001) and BMI significantly improved (33.11 ± 6.67 VS 31.81±6.44, Po0.001).
Follow-up analysis of oGTT For 1008 overweight and obese patients, follow-up data on oGTT were available. The mean observation interval was 1.46±1.33 years. We observed a slight though significant reduction in BMI SDS of À 0.096 ± 0.41 during the observation period. Along with this, the mean levels of all metabolic parameters improved ( Table 2 ). Although 18.7% of the patients showed abnormalities in glucose metabolism at baseline, the percentage decreased to 14.2% at follow-up. When we stratified glucose metabolism into normal, IFG and/or IGT, and T2D, we found that the oGTT category was stable in 76.1% of the patients, while only 9.5% deteriorated and 14.4% improved (Po0.0001, McNemar). Even in children with IGT, more than 70% improved to normal glucose tolerance (Figure 2a We performed multivariable linear regression analyses to identify significant predictors for AUC BG and improvement or deterioration in oGTT. For AUC BG alteration, the change in BMI SDS (b ¼ 1687, Po0.0001) and baseline AUC BG (b ¼ À 0.472, Po0.0001), but not baseline BMI SDS (P ¼ 0.885), baseline age (P ¼ 0.211), sex (P ¼ 0.769) or observation time (P ¼ 0.239), were the most significant predictors. Similarly, the change in BMI SDS predicted improvement in oGTT category in the multivariable logistic models, while it did not achieve statistical significance predicting a deterioration of oGTT. Of the 470 patients who did achieve a weight loss 40.025 BMI SDS, 15.62% improved, whereas in those 451 patients who did not achieve this degree of weight loss, also 10.64% improved the oGTT (P ¼ 0.025). In contrast, of patients with a BMI increase 40.025 SDS, 14.48% deteriorated in oGTT, whereas only 5.70% deteriorated in the group with stable or improved BMI (Po0.0001).
DISCUSSION
We present a multicenter observational study on the longitudinal development of glucose metabolism encompassing more than 1000 obese children and adolescents. The large number of centers specialized in childhood obesity and contributing data to the registry allow an assessment of childhood obesity management and the prevalence of pathologies by simultaneously limiting potential institutional bias.
Alluding to the diagnostic management in obesity centers, we were surprised to find that not even 20% of the children underwent assessment of glucose metabolism by oGTT. The national German consensus guidelines recommend an oGTT in children X10 years old with BMI 490th centile and presence of two risk factors (T2D in 1st/2nd degree relatives, extreme obesity 499.5th centile, signs of insulin resistance, or ethnical risk groups). 10 The percentage of children with follow-up assessment Course of glucose metabolism in obese children A Kö rner et al is even less (o2%), even though an oGTT is recommended in overweight children and adolescents with potential risk factors. 6 In addition, a single abnormal oGTT is not sufficient to diagnose IGT or T2D, and current guidelines require two abnormal tests in asymptomatic patients for diagnosis. In this line, it is even more alarming that the frequency of control oGTTs was so low. The degree of obesity in the patients who did receive diagnostic evaluation was statistically significantly higher, although the magnitude of 0.12 in BMI SDS difference did not appear substantial. In our cohort of more than 11 000 overweight and obese children and adolescents, the prevalence of IGT was about 5% and that of suspicion of T2D was 1%, which are both lower than reported rates from North America of X20%. 11, 12 This lower prevalence in our cohort may be explained by the lower degree of obesity in our sample, which includes 'just' overweight patients, the inclusion of all age groups, and that we did not restrict our analysis to risk groups. However, the fact that our data rely on specialized centers in pediatric obesity will inevitably lead to some enrichment on patients with higher degree/risks or concerns relating to obesity. Nevertheless, the large number of patients included in the study allows a sound estimate of impaired glucose metabolism in obese youth in central Europe. Similar to our results, lower prevalence numbers have also been reported for Italy and other European cohorts. 13 Expectedly, the children that did present with pathology in glucose metabolism were older, suggesting that the exposure to obesity was longer and the extent of obesity in these children was higher. Nevertheless, the association between glucose levels and BMI parameters was rather weak, which suggests that either the variance in glucose levels is higher or/and that the degree of obesity is not the sole trigger for impaired glucose metabolism. Genetic and environmental factors not assessed in the study may modify the risk.
With respect to the long-term outcome of obesity and its complications, the course or changes of glucose metabolism and pathology are even more interesting. In contrast to what may have been expected, we saw an overall reduction, and not a progression, of glucose pathology in our sample. More than half of the children with IGT improved to normal glucose levels in oGTT. This is in line with few long-time follow-up studies showing that even though obesity is a strong risk factor for adult morbidity and mortality, including diabetes and particular cardiovascular disease, diabetes was not a long-term risk factor in these studies. 4, 14, 15 The changes in glucose levels were significantly related to the change in BMI, but not to the absolute BMI at baseline or after the follow-up period. Considering that reductions in BMI SDS were rather modest, one can conclude that weight stabilization and/or the mere attendance in an obesity center was successful in improving glucose metabolism. In addition, in growing children with moderate obesity, BMI may be less suitable than other obesity parameters to predict metabolic impairment. In this regard, the different definitions of the severity of obesity based on BMI centiles, for example, WHO, IOTF VS national references, need to be considered and may also reduce the comparability of studies internationally.
Similar results of improvement of IGT have been reported by smaller studies with one year 16 and up to 5-year follow-up. 17, 18 The result that more than 50% of the obese children with pathologic glucose metabolism convert to normal glucose tolerance underlines the good potential of recovery from impaired glucose metabolism in this age group and that life style intervention should be the first line of treatment of impaired glucose metabolism as opposed to any pharmacological treatment. Course of glucose metabolism in obese children A Kö rner et al
There are several other points to consider. It is well known that insulin sensitivity is affected by the progression of puberty, 19 which may affect our results. However, the group with follow-up oGTT progressed from pubertal stage 2 to 3 in average; hence, deterioration would have been expected. Also, we corrected for pubertal stage and/or age in our multivariable analyses. Furthermore, the low percentage of children receiving a follow-up oGTT (o2%) may not only reflect different diagnostic strategies in the centers, but is also likely to be a result of lost to follow-up children, which is rather typical in obese patients. It is hence possible that the reported data are biased toward these patients who were successful in weight management to some extent. In addition, the mere fact that most data derive from treatment centers, in which children were more likely to receive intervention, would suggest that an improvement of glucose metabolism can be achieved with adherence to the treatment center, even if the 'success' in BMI reduction is not great. Unfortunately, it has also been shown that even in the presence of overt T2D in obese children, the adherence to the treatment center is insufficient. 20 Nevertheless, these results of improvement of glucose metabolism in the majority of obese children and adolescents imply that it is advisable to refrain from immediate pharmacological therapy as a consequence of a single pathological oGTT result in children, but rather support adherence and to follow the course of glucose metabolism longitudinally in these patients. This must be differentiated from treatment regimens of Type 1 diabetes (to which pediatric diabetologists are more accustomed), where immediate and aggressive pharmacologic treatment is indicated. Another reason justifying an observant regimen is the generally poor reproducibility and high intra-individual variability of oGTTs, in particular for 2-h BG levels. 21, 22 Clinically it emphasizes that an isolated abnormal oGTT is not sufficient to diagnose IGT or T2D, which is consistent with current guidelines requiring two abnormal tests in asymptomatic patients to diagnose T2D.
However, irrespective of the fact that the short-term course of glucose metabolism in obese children and adolescents may appear relatively benign, our study can only rely on a mean observation time of about 2 years. One must not disregard the studies showing reduced life expectancy in adults due to obesity 3, 23 and the significantly higher morbidity and mortality. From adult studies it is known that patients with T2D had IGT and/or IFG 5 years earlier 24 and that 2-h BG increases with age and predicts mortality. 25 Hence, longer observation time with several timepoints will be mandatory to assess the long-term outcome and the impact of glucose metabolism in obese children and adolescents.
Finally, in the diagnostic assessment of oGTTs, usually only glucose levels are taken into consideration. This becomes evident in our study, where in only 28.1% baseline insulin was available and not even 15% had insulin levels during the oGTT. One reason for this might be that international classification of pathology in oGTTs is based on glucose levels 8 and hence insulin is disregarded. There are no reference ranges for insulin apart from fasting levels in official guidelines. However, such a regimen disregards the pathophysiology of diabetes, particularly in early stages of the disease. The sequence of events from primary obesity with subsequent insulin resistance and hyperinsulinemia is well known. IGT results from the deviation of the hyperbolic relationship between insulin sensitivity and insulin plasma levels and is hence a sign of decompensation of b-cell function. 26 Although there is a gradual but continuous decline in b-cell function, glucose levels rise relatively slowly. The insulin response during an oGTT in childhood predicted the adult acute insulin response. 27 In adult studies it has been shown that insulin sensitivity declined in each glucose tolerance category. 28 On the other hand, the variability of glucose levels, particularly in children, may even suggest that this is not the best marker, on which most diagnostic and in consequence therapeutic decisions are based. Thus, classification or consideration based on the insulin response, maybe in addition to glucose, might be desirable for clinical studies and clinical management of obese patients.
For the same reason one cannot solely rely on fasting levels. It has been clearly demonstrated that fasting glucose and/or insulin levels and the indices derived from them, do not correctly assess glucose metabolism in obese children. 29 Long-term studies that include the assessment of insulin metabolism will be of high scientific and clinical interest to assess the course of glucose and insulin metabolism in obese children and its impact on sequelae of obesity.
Although the large numbers of patients and the multicentric design is a strength of this study, there are also limitations for the interpretation of the data. Most importantly, it needs to be considered that this is not a standardized prospective designed study applying a uniform protocol, but an observational study based on an ongoing longitudinal patient registry. Hence, the data in part reflect diagnostic management strategies, which are surprisingly different and do not always adhere to current guidelines as outlined above. There is also no centralized measurement of laboratory parameters, particularly glucose and insulin, and we have to face differences in assay procedures. However, one of our main objectives was the intra-individual change in these parameters longitudinally. The low percentage of patients receiving one or two oGTTs results in selection bias and may limit the representativeness of the data for the entire obese population.
CONCLUSION
In a longitudinal observational multicenter analysis, we observed an overall improvement of glucose metabolism in obese children and adolescents treated in specialized obesity centers. Clinically, these results also imply that the diagnosis of IGT or T2D should not be made on the basis of a single oGTT result. Although BMI reduction was a significant predictor, the relatively low magnitude of BMI reduction suggests that weight loss was not the most important factor for the improvement of oGTT. The data may imply that adherence of obese children to specialized treatment centers may be successful to prevent deterioration of parameters of glucose metabolism in the short term.
